Source:http://linkedlifedata.com/resource/pubmed/id/17207415
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2007-1-8
|
pubmed:abstractText |
The commentary seeks to provide a brief history and perspective on the importance of crystal forms of pharmaceuticals as a means of achieving performance criteria. The expanding scope of crystal form selection, emergence of crystal engineering in pharmaceutical science and pharmaceutical co-crystals are topics of this brief review.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
1482-1826
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
9
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
317-26
|
pubmed:meshHeading | |
pubmed:year |
2006
|
pubmed:articleTitle |
Expanding the scope of crystal form evaluation in pharmaceutical science.
|
pubmed:affiliation |
TransForm Pharmaceuticals Inc. Lexington, MA 02421, USA. mpeterson@transformpharma.com
|
pubmed:publicationType |
Journal Article,
Review
|